Bylicki O, Guisier F, Scherpereel A, Daniel C, et al. Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04-2021) trial. Lung Cancer 2024;194:107866.
PMID: 38972083